Barclays Downgrades Endo On 'Difficult Path'

04:49pm, Wednesday, 02'nd Mar 2022 Benzinga
Barclays has downgraded Endo International plc (NASDAQ: ENDP) from Equal-Weight to Underweight with a price target of $2, down from $5, on a 'difficult path.'  The analyst Balaji Prasad sees thre

Barclays Downgrades Endo On ''Difficult Path''

04:49pm, Wednesday, 02'nd Mar 2022 Benzinga
Barclays has downgraded Endo International plc (NASDAQ: ENDP ) from Equal-Weight to Underweight with a price target of $2, down from $5, on a ''difficult path.'' The analyst Balaji Prasad sees three headwinds for the company in 2022: lowered confidence on Qwo, weaker Xiaflex growth, consensus estimates moving lower materially following the Q1 Vaso guidance of down 30% Y/Y. Prasad expects estimates to move closer to his 50% decline expectation. When combined with the … Full story available on Benzinga.com

Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022

03:32pm, Wednesday, 02'nd Mar 2022 Benzinga
Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth quarter, compared to $0.31 in
Barclays has downgraded Endo International (ENDP) to underweight from equal weight citing three headwinds the company faces this year.

US judge eliminates legal defences of Irish-based opioid maker

02:30am, Wednesday, 02'nd Mar 2022 Independent Ireland
A judge in Tennessee found Dublin-headquartered Endo International liable in an opioid-marketing case by default and is stripping the company of its legal defences in an upcoming trial.

Why Shares of Endo International Slumped 22.8% on Tuesday

09:45pm, Tuesday, 01'st Mar 2022 The Motley Fool
The company's shares are down more than 36% so far this year.

Why Shares of Endo International Slumped 22.8% on Tuesday

09:45pm, Tuesday, 01'st Mar 2022 The Motley Fool
The company''s shares are down more than 36% so far this year.
(Bloomberg) -- A judge in Tennessee found Endo International Plc liable in an opioid-marketing case by default and is stripping the company of its legal defenses in an upcoming trial.

Why Endo International Shares Are Falling

05:24pm, Tuesday, 01'st Mar 2022 Benzinga
Endo International PLC (NASDAQ: ENDP ) shares are trading lower after the company issued first-quarter EPS and sales guidance below analyst estimates. The company guided first-quarter EPS of $0.35 to $0.45 versus the consensus estimate of $0.48 and sales of $595 million to $635 million versus the $685.47 million estimate. Endo International also … Full story available on Benzinga.com
The company's shares are down more than 36% so far this year.
The following Management''s Discussion and Analysis of Financial Condition and Results of Operations describes the principal factors affecting the results of operations, liquidity and capital resources and critical accounting estimates of Endo International plc. Management''s Discussion and Analysis of Financial Condition and Results of… The post ENDO INTERNATIONAL PLC – 10-K – Management''s Discussion and Analysis of Financial Condition and Results of Operations appeared first on InsuranceNewsNet .

Endo (ENDP) Surpasses Q4 Earnings and Revenue Estimates

04:19pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
Endo (ENDP) tops Q4 earnings and sales estimates. However, Vasostrict faces generic competition, and the ongoing COVID-19 driven market conditions affect specialty product office-based procedures.
Endo International (ENDP) was stripped of its legal defenses in an upcoming trial in Tennessee over the company’s role in the opioid crisis, Bloomberg reported on Tuesday.The decision…
Endo International plc (ENDP) CEO Blaise Coleman on Q4 2021 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE